Company
Mawson Infrastructure Group, Inc.
Headquarters: North Sydney, NSW, Australia
Employees: 7
CEO: Mr. James Edward Manning
Market Cap
$17.8 Million
USD as of Jan. 1, 2025
Mawson Infrastructure Group, Inc. Categories
Australia Healthcare BiotechnologyAustralia Healthcare Australia Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Mawson Infrastructure Group Inc., a digital infrastructure provider, operates in cryptocurrency mining and digital asset infrastructure activities in the United States and Australia. It owns and operates modular data centers. The company matches energy infrastructure with mobile data center solutions enabling the proliferation of blockchain technology. The company is based in North Sydney, Australia.
Stocks & Indices
Mawson Infrastructure Group, Inc. has the following listings and related stock indices.
Stock: OTC: MIGI wb_incandescent